Protocol library
SingleNot ApprovedMixedVery Low confidenceSourced

BPC-157

An investigational gastric peptide fragment with extensive preclinical claims but extremely limited and uncontrolled human evidence across oral, local and intravenous routes.

Evidence context, not a personal protocol

Quantities below reproduce their stated source context—label, human study, laboratory work or educational guide. They do not assess suitability, product equivalence or individual risk.

Community-reported schedule

Community-reported · not a validated schedule

Community dose schedule

Two community-provenance subcutaneous lines - an educational 5 mg-vial titration and a loading-then-maintenance pattern from forum archives. Community reports only, not a validated or trial-verified schedule.

Evidence source
Reported maximum quantityChoose the maximum quantity reported by this community line. Any earlier phase can be selected below for its arithmetic.

Reported quantities by phase

Select a point for its calculation examples
  1. Loading (up to 3x/day)
    500 mcg
    Per-injection loading anecdotes span roughly 350-650 mcg; frequency and duration are not standardised.
  2. Maintenance (1-2x/day)
    250 mcg
    Step down for maintenance

Vial-aware arithmetic

Reconstitution examples, up to 3 mL

Choose the vial quantity and BAC water first. The diagram and results below update for the selected 500 mcg reported quantity. Higher-strength vials may naturally land outside the 20-30 unit band.

Vial quantity

Choose the quantity printed on the vial.

BAC water added

Use 1, 2 or 3 mL, or enter a custom volume up to 3 mL.

Open the full reverse calculator
Three millilitre research vial, diluent vial and capped U-100 syringe on an ink-blue surface
One small vial, one measured diluent volume and one U-100 scale. The arithmetic connects all three.
BAC water selected
2 mL

Basic example limit: 3 mL maximum. Check the actual vial and product-specific limits.

1 mL BAC
10 units

resulting U-100 draw

Concentration
5 mg/mL
BAC added
1 mL
3 mL BAC
30 units

resulting U-100 draw

Concentration
1.667 mg/mL
BAC added
3 mL

Formula: draw units = selected mg × BAC mL ÷ vial mg × 100. The 20-30 unit band is a measurement reference, not a recommendation. Results are mathematical examples, not preparation instructions.

Dosage and protocol evidence

Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.

Community GuideSubcutaneous in guideDaily
Third-party educational schedule for a 5 mg research vial

200 mcg daily in weeks 1-2, 400 mcg in weeks 3-4 and 600 mcg in weeks 5-8

The source describes a preclinical extrapolation. It is not a validated human dose, and published reviews do not establish a standard injectable regimen.

View source
Community GuideSubcutaneous or oral in channel reportsDaily; cycle not standardised
online research community summaries and reports

The channel spotlight states 200-500 mcg subcutaneously daily or 500-1,000 mcg orally daily, with continuous and cycled use both reported

The same archive says dosing is not established and records mood-related adverse anecdotes after several weeks. These quantities are community provenance, not controlled human dose finding; raw/peptide-education/pe-bpc-157.md:19-25 and 57-64.

View source
Community GuideSubcutaneous, oral or ophthalmic in reportsUp to 3x daily loading, reduced for maintenance
authenticated research-forum (Peppys) reports and an admin protocol

Subcutaneous loading anecdotes cluster around 350-650 mcg up to three times daily, stepping down to roughly 250-350 mcg once or twice daily for maintenance; a separate ophthalmic eye-drop protocol and 500 mcg oral use for gut goals are described independently

Forum provenance from an authenticated archive with usernames omitted. Reported quantities conflict, the archive states human dosing is not established, and the subcutaneous, oral and ophthalmic routes are kept separate rather than interconverted.

View source

Evidence summary

An investigational gastric peptide fragment with extensive preclinical claims but extremely limited and uncontrolled human evidence across oral, local and intravenous routes.

Protocol basis

The page is based on reviews that distinguish a large animal literature from a handful of uncontrolled human observations. That evidence does not support a standard oral or injectable schedule.

Community provenance (Peppys)

An authenticated research-forum archive records subcutaneous loading in the region of 350-650 mcg up to three times daily, with lower maintenance dosing afterwards, alongside a separate ophthalmic eye-drop protocol and oral use for gut-focused goals. The same archive states that human dosing is not established and records conflicting quantities. Usernames are omitted and figures are logged as community provenance without endorsement. The planner above reproduces the arithmetic of these reported quantities; it does not validate them.

What remains uncertain

Pharmaceutical-grade formulation, human exposure-response, longer-term safety and controlled efficacy are all unresolved.

Warnings and contraindications

No approved BPC-157 formulation or validated dosing regimen exists.
Published human information involves fewer than 30 participants across uncontrolled pilots.
Route, purity, stability and pharmacokinetics cannot be inferred from animal experiments.
Organised research bench with labelled storage tray, vial rack, notebook and thermometer
A clean workspace supports traceability. It does not establish sterility.

Shared across protocols

Supplies and general handling

Keep the universal checklist short. Product-specific labelling and source documentation always take priority over a general guide.

Research vial

Select the labelled vial quantity used in the calculation.

View Peppys vial

Bacteriostatic water

Use only a diluent appropriate to the research method and formulation.

View Peppys BAC water

U-100 measuring syringe

Use a new sterile device for every entry. Source locally.

Source locally

Wipes and sharps container

Plan clean handling and immediate sharps disposal. Source locally.

Source locally

Storage follows the label

Do not apply a universal refrigerator rule. Follow the product, diluent and study documentation for temperature, light and expiry.

Use sterile equipment once

CDC injection-safety guidance calls for a new sterile needle and syringe for each injection and entry into a medication container.

Stability is formulation-specific

Do not infer a post-mixing lifetime from BAC water alone. Discard material when identity, integrity or sterility is in doubt.